amyotrophic-lateral-sclerosis

Documents about amyotrophic-lateral-sclerosis

• Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS#888121ClinicalTrials.gov
• Study of Electrical Impedance Myography (EIM) in ALS#847252ClinicalTrials.gov
• Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS)#871398ClinicalTrials.gov
• Author Correction: Autoimmune response to C9orf72 protein in amyotrophic lateral sclerosis#5592Europe PMC
• “Silent Echoes of the Day: Dream Content Analysis in Amyotrophic Lateral Sclerosis”.#165796NCBI PubMed Central
• A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis#215482IRIS
• CYP2D6 variants in amyotrophic lateral sclerosis: an association study of risk and survival#384784HAL (France)
• Plasma creatinine and amyotrophic lateral sclerosis prognosis: a systematic review and meta-analysis#384786HAL (France)
• Some CSF Kynurenine Pathway Intermediates Associated with Disease Evolution in Amyotrophic Lateral Sclerosis#384800HAL (France)
• Evaluation of arterial blood gas parameters as prognostic markers in amyotrophic lateral sclerosis#384815HAL (France)
• ASSESS ALL ALS Study#812550ClinicalTrials.gov
• Anticipated Patient and Caregiver Burden#844193ClinicalTrials.gov
• Open Label Study: Treatment of ALS Fatigue With PolyMVA#874696ClinicalTrials.gov
• Exogenous Toxicants and Genetic Susceptibility in ALS#911679ClinicalTrials.gov
• Volume Mode Non-invasive Ventilation in Amyotrophic Lateral Sclerosis#860089ClinicalTrials.gov
• Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing#860132ClinicalTrials.gov
• Implanted brain-computer interface functionality during nighttime in late-stage amyotrophic lateral sclerosis.#150007NCBI PubMed Central
• Strategic Amyotrophic Lateral Sclerosis Australia-Systems Genomics Consortium (SALSA-SGC): cohort profile.#308646NCBI PubMed Central
• Metabolomic analyses of amyotrophic lateral sclerosis, muscle cramps, and TJ-68 treatment.#380787NCBI PubMed Central
• Metabolomics: A Tool to Understand the Impact of Genetic Mutations in Amyotrophic Lateral Sclerosis#384794HAL (France)
• Learning a distance for the clustering of patients with amyotrophic lateral sclerosis#384838HAL (France)
• ZDHHC17 Links S-Acylation, Huntington Disease, VCP-associated Multisystem Proteinopathy, and Amyotrophic Lateral Sclerosis.#627784bioRxiv / medRxiv
• Dysphagia, QoL and Attitudes Towards PEG in ALS Patients#811756ClinicalTrials.gov
• A New Eye-based Communication Device for ALS Patients#848653ClinicalTrials.gov
• Personalized Antisense Oligonucleotide Therapy for Participants With TARDBP ALS#885940ClinicalTrials.gov
• Exploratory Evaluation of [11C]MPC6827#909235ClinicalTrials.gov
• Treatment of FUS-Related ALS With Betamethasone - The TRANSLATE Study#992713ClinicalTrials.gov
• Systemic ELOVL6 activity predicts survival and represents a modifiable target of amyotrophic lateral sclerosis#243526bioRxiv / medRxiv
• TDP-43 proteinopathy as a biomarker and therapeutic target in amyotrophic lateral sclerosis.#340404NCBI PubMed Central
• Aβ1-42 and Tau as Potential Biomarkers for Diagnosis and Prognosis of Amyotrophic Lateral Sclerosis#384793HAL (France)
• Distinct Clinical Associations of Blood Tau Biomarkers and Neurofilament Light in Amyotrophic Lateral Sclerosis#424123bioRxiv / medRxiv
• Integrated multi-omics identification of m6A-SNP-related diagnostic biomarkers in amyotrophic lateral sclerosis.#685645NCBI PubMed Central
• Validation of the "ExSpiron©" in Patients With ALS#827546ClinicalTrials.gov
• Predictive Factors for the Diagnosis of Early Noninvasive Ventilation Equipment#854450ClinicalTrials.gov
• Personalized Antisense Oligonucleotide Therapy for A Single Participant With TARDBP ALS#877951ClinicalTrials.gov
• NEDD8, stress granules, and amyotrophic lateral sclerosis: unveiling the therapeutic potential of the NEDP1 protease#971174HAL (France)
• Safety Study of HLA-haplo Matched Allogenic Bone Marrow Derived Stem Cell Treatment in Amyotrophic Lateral Sclerosis#856673ClinicalTrials.gov
• First in Human (FIH) Study of ALN-SOD in Adult Participants With Amyotrophic Lateral Sclerosis Associated With Mutation in the SOD1 Gene (SOD1-ALS)#980107ClinicalTrials.gov
• Downregulation of miRNAs Accompanies Increased HERV-K (HML-2) Expression in Amyotrophic Lateral Sclerosis.#30637NCBI PubMed Central
• Synaptic Plasticity Fragility Underlies a Microglial Pruning Continuum in Major Depressive Disorder and Amyotrophic Lateral Sclerosis.#30704NCBI PubMed Central
• Oral Health in Amyotrophic Lateral Sclerosis: Feasibility of Oral Screening and Determinants of Poor Outcomes.#154481NCBI PubMed Central
• LINC00205 acts as a multivalent scaffold promoting FUSP525L recruitment in Amyotrophic Lateral Sclerosis stress granules#162287bioRxiv / medRxiv
• ECAS-Based Neuropsychological Phenotyping in Amyotrophic Lateral Sclerosis: A Retrospective Study Comparing Different Algorithms#176246Zenodo (CERN)
• APOE ε4 influences the widespread TDP-43 pathological subtype in sporadic amyotrophic lateral sclerosis.#193409NCBI PubMed Central
• Distinct UNC13A Haplotype Blocks Define Disease Severity and Survival in Chinese Amyotrophic Lateral Sclerosis.#265480NCBI PubMed Central
• Seeing amyotrophic lateral sclerosis in a multi-omic perspective#365106Open Access LMU
• Neuromuscular ultrasound as a biomarker in the SOD1 mouse model of amyotrophic lateral sclerosis.#371689NCBI PubMed Central
• NEK1 autophosphorylation is disrupted by amyotrophic lateral sclerosis-associated missense variants: activity biomarkers and structural insights#381662bioRxiv / medRxiv
• Implication of Central Nervous System Barrier Impairment in Amyotrophic Lateral Sclerosis: Gender-Related Difference in Patients#384816HAL (France)
• Digital Remote Assessment of Motor and Speech Changes in Amyotrophic Lateral Sclerosis: Longitudinal Observational Study.#420921NCBI PubMed Central